phrykt

Bristol Myers Squibb Co (BMY): who owns it and who trades it

As of Nov 16, 2026, BMY insiders reported 5 open-market sales worth $2.5M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was David V Elkins (CFO), with $1.9M. 10 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Bristol Myers Squibb

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns BMY

2,507 funds and institutions reported BMY shares worth $96.2B at the end of Q2 2026, about 82% of the company. The largest holder is BlackRock, Inc. with 8.8%.

Funds and institutions (13F) 82%Everyone else 18%

10 largest owners, by share of the company

BlackRock, Inc.8.8%
Vanguard Capital Management LLC6.5%
State Street Corp5.0%
JPMorgan Chase & Co3.5%
Charles Schwab Investment Management Inc3.3%
Geode Capital Management, LLC2.8%
Vanguard Portfolio Management LLC2.3%
Norges Bank1.8%
Bank of America Corp1.7%
T. Rowe Price Associates1.6%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.180.38M8.83%$10.4B+5%
Vanguard Capital Management LLC133.34M6.53%$7.7B+1%
State Street Corp102.41M5.01%$5.9B+4%
JPMorgan Chase & Co71.71M3.51%$4.2B–
Charles Schwab Investment Management Inc67.60M3.31%$3.9B+11%
Geode Capital Management, LLC56.44M2.76%$3.2B+2%
Vanguard Portfolio Management LLC46.87M2.30%$2.7B+1%
Norges Bank36.87M1.81%$2.1B–
Bank of America Corp34.05M1.67%$2B+4%
T. Rowe Price Associates31.71M1.55%$1.8B+209%
Morgan Stanley29.01M1.42%$1.7B-1%
AQR Capital Management LLC27.36M1.34%$1.6B-8%
Ameriprise Financial Inc26.67M1.31%$1.5B+1%
Primecap Management Co24.92M1.22%$1.4B-0%
Northern Trust Corp24.92M1.22%$1.4B+1%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC22.84M1.12%$1.3B+1%
Bank of New York Mellon Corp21.82M1.07%$1.3B-6%
Independent Franchise Partners LLP21.79M1.07%$1.3B+2%
Dimensional Fund Advisors LP19.69M0.96%$1.1B+5%
Legal & General Group Plc17.02M0.83%$981M+1%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, BMY insiders reported $0 of open-market purchases and $2.5M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$2.5M
5 trades, 4 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Nov 5, 2026
Filed Nov 6, 2026

Purchases and sales by month

$1.9M$1.9MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 5, 2026Julia A HallerDirectorSale3,800$63.31$241KForm 4
Sep 9, 2026Cristian MassacesiVice presidentSale6,249$64.57$403KForm 4
Aug 25, 2026Phil M HolzerVice presidentSale500$67.50$33.8KForm 4
Apr 1, 2026David V ElkinsCFOSale25,519$61.60$1.6MForm 4
Apr 1, 2026David V ElkinsCFOSale4,481$62.05$278KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
David V ElkinsEVP, Chief Financial Officer–$1.9MApr 1, 2026
Cristian MassacesiEVP,Chief Med Offr,Head of Dev–$403KSep 9, 2026
Julia A HallerDirector–$241KNov 5, 2026
Phil M HolzerSVP and Controller–$33.8KAug 25, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

BMY short interest

Low short interest. 2.3% of BMY shares are sold short: about 1 share in 44. Over the last 12 reports the number of shares short went up 28%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 46.85M BMY shares were sold short, 2.3% of the shares outstanding, down 6.2% from the report before. At the average daily volume of 11.06M shares, buying them all back would take about 4.2 trading days (days to cover).

Shares short, % of all shares

2.29%May 15Oct 302.68%

Days to cover

4.2May 15Oct 306.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202646.85M2.29%-6%11.06M4.2
Oct 15, 202649.95M2.45%+9%13.69M3.6
Sep 30, 202645.85M2.24%+9%15.25M3.0
Sep 15, 202641.97M2.05%-5%7.24M5.8
Aug 31, 202644.07M2.16%-4%8.37M5.3
Aug 14, 202645.85M2.24%-12%13.18M3.5
Jul 31, 202652.34M2.56%+16%11.29M4.6
Jul 15, 202644.94M2.20%+11%10.60M4.2
Jun 30, 202640.53M1.98%+2%16.38M2.5
Jun 15, 202639.60M1.94%+3%11.89M3.3
May 29, 202638.51M1.89%+5%11.14M3.5
May 15, 202636.72M1.80%+17%10.38M3.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded BMY

Since Nov 17, 2024, 9 members of Congress reported 5 purchases and 11 sales of BMY. The latest was a sale by Mike Kelly on May 7, 2026, reported Jun 11, 2026.

Purchases 5Sales 11

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
May 7, 2026Mike Kelly (R-PA)Sale$15K–$50KSpouseJun 11, 2026Report
Mar 27, 2026Alan Armstrong (R-OK)Purchase$1K–$15KSelfJul 21, 2026Report
Dec 19, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfJan 12, 2026Report
Dec 18, 2025Julie Johnson (D-TX)Sale$1K–$15KJointJan 15, 2026Report
Nov 13, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointDec 11, 2025Report
Nov 12, 2025Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfDec 15, 2025Report
Oct 9, 2025Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfNov 18, 2025Report
Aug 14, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointSep 11, 2025Report
Jun 24, 2025Virginia Foxx (R-NC)Sale$1K–$15KSelfJul 3, 2025Report
May 12, 2025Jefferson Shreve (R-IN)Sale$15K–$50KSelfJun 22, 2025Report
Apr 28, 2025Julia Letlow (R-LA)Sale$1K–$15KSelfJan 13, 2026Report
Apr 15, 2025Tommy Tuberville (R-AL)Sale$1K–$15KSelfMay 15, 2025Report
Apr 1, 2025Julie Johnson (D-TX)Sale$1K–$15KJointMay 14, 2025Report
Mar 27, 2025Greg Landsman (D-OH)Sale$1K–$15KJointApr 8, 2025Report
Jan 15, 2025Julie Johnson (D-TX)Purchase$1K–$15KJointFeb 12, 2025Report
Dec 6, 2024Virginia Foxx (R-NC)Purchase$1K–$15KSelfJan 6, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Bristol Myers Squibb company events

Bristol Myers Squibb filed 7 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Oct 29, 2026.

  1. Oct 29, 2026ResultsReleased financial results. Filing
  2. Jul 30, 2026ResultsReleased financial results. Filing
  3. May 8, 2026VoteReported shareholder vote results. Filing
  4. Apr 30, 2026ResultsReleased financial results. Filing
  5. Feb 5, 2026ResultsReleased financial results. Filing
  6. Jan 12, 2026AnnouncementShared information with investors. Filing
  7. Nov 18, 2025AnnouncementBristol-Myers Squibb Company issued a press release announcing the early participation results, amendment and early settlement of its previously announced cash tender offers to purchase notes issued by Bristol Myers Squibb. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

How Bristol Myers Squibb makes money

Legacy Brands brought in 45% of Bristol Myers Squibb's revenue ($21.8B of $48.2B) in 2025. Orencia was next, at 8%.

By product or service, 2025

Legacy Brands$21.8B · 45%
Orencia$3.7B · 8%
Revlimid$3B · 6%
Yervoy$2.9B · 6%
Pomalyst/Imnovid$2.7B · 6%
Reblozyl$2.3B · 5%
Other Growth Brands$1.9B · 4%
Alliance And Other Revenues$1.4B · 3%
Breyanzi$1.4B · 3%
Opdualag$1.2B · 2%
Camzyos$1.1B · 2%
Other revenues$992M · 2%

By region, 2025

United States$33.3B · 69%
Other countries$13.8B · 29%
Other Region$1.1B · 2%

From Bristol Myers Squibb's annual report (10-K) for the year ended Dec 31, 2025, filed Feb 11, 2026. The company chooses how to group its revenue, so the parts differ from one company to the next. Read the filing · How the biggest companies make money

Bristol Myers Squibb financials

Famous investors that hold BMY

10 of the 50 well-known investors we track reported holding BMY in their latest 13F filing. The largest position is Richard Pzena's, worth $889M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Richard Pzena · Pzena Investment ManagementQ3 202614.24M$889M2.6%-16%
Israel Englander · Millennium ManagementQ3 20262.20M$137M0.1%+193%
Ken Griffin · Citadel AdvisorsQ3 20261.14M$71.3M0.0%-27%
Paul Tudor Jones · Tudor Investment CorpQ3 20261.03M$64.5M0.3%New
Jeremy Grantham · GMOQ3 2026463,660$28.9M0.1%+13%
Ken Fisher · Fisher Asset ManagementQ3 2026213,131$13.3M0.0%+23%
Ray Dalio · Bridgewater AssociatesQ3 202677,808$4.9M0.0%New
Bill Miller · Miller Value PartnersQ3 202669,500$4.3M0.9%No change
Lee Ainslie · Maverick CapitalQ3 202634,008$2.1M0.0%New
Jim Simons · Renaissance TechnologiesQ3 202618,200$1.1M0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Bristol Myers Squibb Co (BMY) stock

Who owns the most BMY stock?

The largest reported owner of Bristol Myers Squibb Co (BMY) is BlackRock, Inc., with 8.8% of the company. In total, 2,507 funds and institutions reported holding BMY at the end of Q2 2026, together about 82% of the shares. See the largest owners.

Are BMY insiders buying or selling?

In the last 12 months, BMY insiders reported no open-market purchases and 5 sales worth $2.5M. The latest trade was on Nov 5, 2026. See every trade.

What is the short interest in BMY?

As of Oct 30, 2026, 46.85M BMY shares were sold short, 2.3% of the shares outstanding, down 6.2% from the report before. At the average daily volume of 11.06M shares, buying them all back would take about 4.2 trading days (days to cover). See the history.

Have members of Congress traded BMY?

Yes. 9 members of Congress reported 5 purchases and 11 sales of BMY since Nov 17, 2024. The latest was reported on Jul 21, 2026. See the trades.

How does Bristol Myers Squibb make money?

Legacy Brands brought in 45% of Bristol Myers Squibb's revenue ($21.8B of $48.2B) in 2025. Orencia was next, at 8%. See the full split.

Which famous investors hold BMY?

10 of the 50 well-known investors we track reported BMY in their latest 13F filing, including Richard Pzena, Israel Englander, Ken Griffin. The largest position is worth $889M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.